Answers are grounded in this paper and cite their sources.
Ulcerative colitis (UC) is a persistent inflammatory condition affecting the mucosal layer of the colon, with limited treatment options available. Diarylheptanoids, bioactive secondary metabolites found in Curcuma plants, possess diverse anti‐inflammatory and antioxidant properties. However, the biological activities of 1,7‐diphenyl‐(6 E )‐6‐hepten‐3‐ol (DPHP), a linear diarylheptanoid derived from Curcuma comosa rhizomes, remain largely unexplored. This study was conducted to investigate the antioxidant and anti‐inflammatory mechanisms of DPHP in dextran sodium sulfate (DSS)‐induced colitis mice and lipopolysaccharide (LPS)‐treated RAW 264.7 macrophages. The results showed that DPHP supplementation considerably alleviated the severity of DSS‐induced colitis by reducing the disease activity index, minimizing colon damage and neutrophil infiltration, and preventing body weight loss and colon shortening. DPHP inhibited inflammation in both DSS‐induced colitis mice and LPS‐treated macrophages by suppressing the c‐Jun N‐terminal kinases/nuclear factor kappa B pathway. Additionally, DPHP treatment effectively reduced reactive oxygen species formation and oxidative damage by upregulating the expression of antioxidant enzymes, likely via regulation of the adenosine monophosphate‐activated protein kinase/nuclear factor‐erythroid 2 related factor 2 (Nrf2) pathway. Moreover, the antioxidant and anti‐inflammatory effects of DPHP were significantly abrogated upon blocking Nrf2/heme oxygenase‐1 activation. Overall, these findings shed light on the protective effects of DPHP against oxidative stress and inflammation through coordinated Nrf2 and nuclear factor‐kappa B (NF‐κB) pathway modulation, underscoring its potential as a therapeutic agent for preventing and treating UC.
No takes yet. Share an insight, caveat, or question.
Truong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: